1. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa. (29th January 2014) Authors: Santagostino, E.; Lentz, S. R.; Busk, A. K.; Regnault, A.; Iorio, A. Journal: Haemophilia Issue: Volume 20:Number 4(2014:Jul.) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa. (29th January 2014) Authors: Santagostino, E.; Lentz, S. R.; Busk, A. K.; Regnault, A.; Iorio, A. Journal: Haemophilia Issue: Volume 20:Number 4(2014:Jul.) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of severe haemophilia A on patients' health status: results from the guardian™ 1 clinical trial of turoctocog alfa (NovoEight®). (12th February 2015) Authors: Ozelo, M.; Chowdary, P.; Regnault, A.; Busk, A. K. Journal: Haemophilia Issue: Volume 21:Number 4(2015:Jul.) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗